Literature DB >> 8389201

The human papillomavirus E7 protein as a transforming and transactivating factor.

K Münger1, W C Phelps.   

Abstract

The HPV proteins encoded by the early viral genes, including E6 and E7, are thought to subvert the normal regulatory pathways of infected cells to accommodate viral replication. Mechanistically some of this is accomplished by protein-protein interactions between viral proteins and a number of key cellular regulatory proteins that include tumor suppressor gene products. By undermining cellular regulatory pathways the HPV oncogenes cause hyperproliferation and the perturbation of normal cellular differentiation pathways. Although expression of the high-risk HPV-encoded E6 and E7 oncoproteins may be important prerequisites for cellular transformation, it is very likely that additional cellular changes are necessary for carcinogenic progression. The elucidation of the role of the early HPV genes in the initiation and/or maintenance of carcinogenic progression will continue to be a fascinating area of investigation and may reveal new opportunities for antiviral therapy and antitumor intervention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389201     DOI: 10.1016/0304-419x(93)90025-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

Review 1.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

Authors:  K Butz; C Denk; A Ullmann; M Scheffner; F Hoppe-Seyler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin.

Authors:  O Rey; S Lee; N H Park
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways.

Authors:  Robbert J C Slebos; Nico Jehmlich; Brandee Brown; Zhirong Yin; Christine H Chung; Wendell G Yarbrough; Daniel C Liebler
Journal:  Int J Cancer       Date:  2012-07-20       Impact factor: 7.396

Review 5.  Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

6.  Interactions with pocket proteins contribute to the role of human papillomavirus type 16 E7 in the papillomavirus life cycle.

Authors:  Asha S Collins; Tomomi Nakahara; Anh Do; Paul F Lambert
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals.

Authors:  I Arany; T Evans; S K Tyring
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

8.  Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression.

Authors:  S L Giannini; W Al-Saleh; H Piron; N Jacobs; J Doyen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.

Authors:  Ivan Martinez; Jun Wang; Kenosha F Hobson; Robert L Ferris; Saleem A Khan
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

10.  Characterization of human papillomavirus type 16 activity in separate biopsies from a carcinoma of the cervix uteri.

Authors:  D Kube; J Janda; K D Johannsmeyer; S Bergmann; U Kiessling
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.